Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market by Test Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA and Competitive (ELISA) for Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantification and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market is expected to reach USD 547.6 million by 2022, growing at a CAGR of 4.6% between 2017 and 2022.

Request Brochure Request Discount

28-Jul-2017 | Number of pages: 110 | Report Code: ZMR-1978 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the enzyme-linked immunosorbent assay (ELISA) testing market on a global and regional level. The study provides historic data of 2016 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the enzyme-linked immunosorbent assay (ELISA) testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the enzyme-linked immunosorbent assay (ELISA) testing market on a global level.

In order to give the users of this report a comprehensive view on the enzyme-linked immunosorbent assay (ELISA) testing market, we have to include competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein test type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the enzyme-linked immunosorbent assay (ELISA) testing market by segmenting the market based on test type, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. Based on test type the market is segmented into sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Key applications covered under this study include Immunology, inflammation, infectious diseases, cancer, protein quantification and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for enzyme-linked immunosorbent assay (ELISA) testing based on individual test type and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.

This report segments the global enzyme-linked immunosorbent assay (ELISA) testing market as follows:

Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Test Type Segment Analysis

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and portable ELISA
  • Competitive ELISA

Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Application Segment Analysis

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Others

Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.